KSHB: ‘Have Hope’: Study Shows Immunotherapy Continues To Change Future of Cancer Treatment

A new phase in a clinical trial for treating certain kinds of tumors with immunotherapy continues to pave the way for the future of treating patients with cancer.

Immunotherapy is making a big impact in the lives of patients like Michael Delaney, who battles a rare cancer known as thymic carcinoma and has received almost 200 rounds of immunotherapy.

KSHB talked with Dr. Marc Roth, Medical Director of Gastrointestinal Oncology at Saint Luke's, and Dr. Timothy Pluard, Medical Director at Saint Luke's Cancer Institute, about the latest research on immunotherapy and how it works.